
Oncology
5 Jun 2026
Stereotactic Radiotherapy Effective in Kidney Cancer
Long-term data from the FASTRACK II trial suggest stereotactic ablative body radiotherapy offers durable local control and a favourable safety profile in patients with primary renal cell carcinoma who are unsuitable for surgery.

General Healthcare
4 Jun 2026
New Life-Extending Drug for Women with Ovarian Cancer
A new ovarian cancer drug, mirvetuximab soravtansine, has been approved on the NHS, offering improved survival and better tolerability for patients with treatment-resistant ovarian cancer through a targeted antibody-drug approach.




























